Table 1.
Group | Experimental group | Vaccine | α-GalCer (μg/kg) | Challenge virusc | N |
---|---|---|---|---|---|
1 | Mock – CO99 | Vehiclea | Vehicleb | H3N2 CO99 | 3 |
2 | TX98ΔNS1 + 0μg αGC – CO99 | TX98ΔNS1 | Vehicle | H3N2 CO99 | 2 |
3 | TX98ΔNS1 + 10μg αGC – CO99 | TX98ΔNS1 | 10 | H3N2 CO99 | 3 |
4 | TX98ΔNS1 + 50μg αGC – CO99 | TX98ΔNS1 | 50 | H3N2 CO99 | 3 |
5 | TX98ΔNS1 + 100μg αGC – CO99 | TX98ΔNS1 | 100 | H3N2 CO99 | 3 |
aVirus-free Dulbecco's Modified Eagle's Medium (DMEM)
b50 μL/kg of dimethyl sulfoxide (DMSO) (the volume used to dissolve the 100 μg/kg dose of α-GalCer used in group 5)
c1 x 106 TCID50 H3N2 A/Swine/Colorado/23619/1999 administered intratracheally (i.t.) in 2 mL of DMEM